GlassScriptPhysician profile
Douglas Scott Maxey
NPI 1255573739
$10,229.30
in general payments reported to CMS, 2019-2025
44 companies · $820 in 2025
The $820 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,048 · 2020: $2,094 · 2021: $1,125 · 2022: $893 · 2023: $629 · 2024: $620 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,068.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $4,543.26 | 2019-2025 | Xtampza |
| Biodelivery Sciences International, INC. | $901.76 | 2019-2021 | |
| Forte Bio-Pharma LLC | $772.40 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Medtronic USA, INC. | $627.75 | 2019-2020 | |
| Horizon Therapeutics Plc | $388.29 | 2019-2022 | |
| Abbott Laboratories | $320.18 | 2019-2025 | Eterna, Proclaim |
| Medtronic, INC. | $304.79 | 2021-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $269.56 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $242.71 | 2019-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $240.89 | 2019-2025 | Relistor |
| Nevro Corp. | $214.40 | 2019-2024 | Senza |
| Abbvie INC. | $124.16 | 2022-2025 | |
| Spr Therapeutics, INC | $115.17 | 2020-2023 | Sprint Pns System |
| Almatica Pharma LLC | $108.29 | 2021-2022 | |
| Daiichi Sankyo INC. | $87.15 | 2019 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Maxey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.